Subramanian Kumar

418 citations
8 papers · 357 indexed · h-index 8

Subramanian Kumar

8 papers receiving 348 citations

Peers

Subramanian Kumar
Comparison fields: 5 of 83
  • Biochemistry 75
  • Pharmacology 54
  • Complementary and alternative medicine 46
  • Biochemistry 27
  • Endocrinology, Diabetes and Metabolism 56
Replace Zhi-Nan Xiang with:
Zhi-Nan Xiang China
Thangarasu Silambarasan India
Aikkarach Kettawan Thailand
Yoswaris Semaming Thailand
Martina S. Savova Bulgaria
Basit L. Jan Saudi Arabia
Chin-Lin Hsu Taiwan
Tomáš Siatka Czechia
Luna Costa Vasconcelos Brazil
Zhuliang Tan Canada
Subramanian Kumar relative to Zhi-Nan Xiang China Zhi-Nan Xiang's profile →
Citations per field
00.5×1.5×2.3×
Zhi-Nan Xiang · 1×
Citations per year

Countries citing papers authored by Subramanian Kumar

Since Specialization
Citations

This map shows the geographic impact of Subramanian Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subramanian Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subramanian Kumar more than expected).

Fields of papers citing papers by Subramanian Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subramanian Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subramanian Kumar. The network helps show where Subramanian Kumar may publish in the future.

Co-authorship network

The 5 scholars most cited alongside Subramanian Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Subramanian Kumar Line = papers co-authored together Subramanian Kumar links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 201514
2 201438
3 201426
4 201253
5 201275
6 201240
7 201199
8
Evaluation of the Protective Effects of Omega-3 Fatty Acids against Methotrexate Induced Testicular Toxicity in Male Albino Mice
201112

About Subramanian Kumar

Subramanian Kumar is a scholar working on Biochemistry, Biochemistry and Nutrition and Dietetics, having authored 8 papers that have together received 357 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (4 papers), Antioxidant Activity and Oxidative Stress (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Free Radicals and Antioxidants (2 papers), Sodium Intake and Health (1 paper), Cholesterol and Lipid Metabolism (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper) and Phytochemicals and Antioxidant Activities (1 paper). The work is most often cited by research in Biochemistry (75 citations), Pharmacology (54 citations) and Complementary and alternative medicine (46 citations). Subramanian Kumar has collaborated with scholars based in India and United States. Frequent co-authors include Prahalathan Pichavaram, Boobalan Raja, Santosh Kumar Mishra, Jeganathan Manivannan and Thangarasu Silambarasan. Their work appears in journals such as Redox Report, Naunyn-Schmiedeberg s Archives of Pharmacology, Environmental Toxicology and Pharmacology, European Journal of Pharmacology and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026